News from china sxt pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 14, 2022, 14:30 ET China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Dec 16, 2021, 08:00 ET China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC) announced today that on December 14, 2021, the Company received a...

Oct 18, 2021, 08:00 ET China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Feb 19, 2021, 08:00 ET China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Feb 11, 2021, 08:00 ET China SXT Pharmaceuticals, Inc. Enters into Non-Binding LOI to Acquire Jiangsu Renji Pharmaceutical Chain Co., Ltd.

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company") announced today that it has entered into a non-binding letter of intent ...

Sep 09, 2020, 09:00 ET NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price Requirement

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Mar 16, 2020, 09:16 ET China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Jan 16, 2020, 08:00 ET China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Jan 03, 2020, 10:30 ET China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC) announced today that on December 27, 2019 the Company received a...

Sep 11, 2019, 07:00 ET China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Aug 19, 2019, 08:00 ET China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Aug 12, 2019, 08:00 ET China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Jul 03, 2019, 08:00 ET China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

May 22, 2019, 11:20 ET China SXT Pharmaceuticals, Inc. Being Admitted to Hi-tech Zone of Huangshan City in Anhui Province

China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development,...

Apr 17, 2019, 09:01 ET China SXT Pharmaceuticals, Inc. Announces Pricing of a $15 Million PIPE Financing

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research,...

Apr 02, 2019, 06:30 ET China SXT Pharmaceuticals, Inc. Receives National High-tech Enterprise Qualification

China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ:SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, ...

Mar 28, 2019, 06:30 ET China SXT Pharmaceuticals, Inc. Announces Financial Results for the Six Months Ended September 30, 2018

China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development,...

Jan 04, 2019, 07:30 ET China SXT Pharmaceuticals, Inc. Announces Final Closing of Initial Public Offering

China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development,...

Jan 02, 2019, 13:30 ET China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ:SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, ...

Sep 28, 2018, 17:15 ET China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share

China SXT Pharmaceuticals, Inc. (the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and ...